Recurrent World Health Organization (WHO) Grade II Glioma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Recurrent World Health Organization (WHO) Grade II Glioma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT04540107

Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma

This trial studies how well serial magnetic resonance (MR) imaging and MR spectroscopic imaging work in characterizing lower grade glioma. Diagnostic procedures…

United States300 participantsStarted 2017-01-11

Treatment: Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Imaging

All recent trials (3 shown)

SuspendedPhase 1

NCT04485559

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

This phase I trial studies the side effects and best dose of trametinib and everolimus in treating pediatric and young adult patients with gliomas that have com…

United States50 participantsStarted 2020-12-09

Treatment: Everolimus, Trametinib

CompletedPhase 2

NCT04044937

Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms

This phase II trial studies how well F-18 fluoroethyltyrosine (fluoroethyltyrosine) works in detecting tumors in participants with intracranial tumors that have…

United States143 participantsStarted 2018-10-29

Treatment: F-18 Fluoroethyltyrosine (FET), Positron Emission Tomography (PET)